Esophageal cancer remains a major health threat worldwide, with considerable regional disparities in incidence and mortality.

A critical study sheds light on the growing global burden of esophageal cancer, outlining its significant impact and the ...

PAVmed (NASDAQ:PAVM – Free Report) had its price objective decreased by Ascendiant Capital Markets from $21.00 to $19.00 in a research report report published on Monday,Benzinga reports. Ascendiant ...

A 45-year-old man from Shimla, plagued by chronic liver disease and severe esophageal complications, has been given a new ...

A 45-year-old man from Shimla, had been suffering from chronic liver disease (cirrhosis), a condition where the liver shrinks ...

A partnership with Central Arizona Fire and Medical Authority and a DNA test company provides esophageal cancer screenings to ...

(Nasdaq: PAVM), today announced that it has submitted its complete clinical evidence package for its EsoGuard ® Esophageal DNA Test in support of a Request for Reconsideration of Local Coverage ...

1 Department of Anesthesiology, Children’s Hospital of Fudan University, Shanghai, China 2 Department of Cardiothoracic Surgery, Children’s Hospital of Fudan University, Shanghai, China Background: ...

MONDAY, Nov. 18, 2024 (HealthDay News) -- For patients with unresectable locally advanced esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) followed by immunochemotherapy (iCT ...

(a) Diagnosed with achalasia; (b) Underwent peroral endoscopic myotomy (POEM) surgery for achalasia; (c) Severe reflux symptoms 23 months later; (d) Esophageal squamous cell carcinoma located 25 ...

Studies have demonstrated the efficacy of perioperative chemotherapy for treating esophageal adenocarcinoma as well as trimodality therapy for managing esophageal cancer, but survival outcomes ...